Oral dosage forms of gemcitabine derivatives

Details for Australian Patent Application No. 2006223757 (hide)

Owner Clavis Pharma AS

Inventors Myhren, Finn; Eriksen, Ole Henrik; Sandvold, Marit Liland

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006223757

PCT Pub. Number WO2006/098628

Priority 20051467 18.03.05 NO

Filing date 7 March 2006

Wipo publication date 21 September 2006

International Classifications

A61K 31/7068 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/098628 Priority application(s): WO2006/098628

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006223758-Process for manufacture of feed for aquaculture species

2006223754-Dermatologic use of milk proteins